In today's episode, part of our MBC webinar series, we delve into the San Antonio Breast Cancer Symposium (SABCS). We aim to break down the overwhelming amount of information into digestible insights with new snippets coming out each day this week!
Today we discuss key findings, particularly on inflammatory breast cancer (IBC) and invasive lobular carcinoma (ILC), with insights from Amy Parliman, a member of our MBC leadership team.
Amy highlights the advancements in technology that outpace current treatment options and the importance of recognizing the unique challenges of diagnosing IBC and ILC due to their imaging difficulties. She shares that the symposium acknowledged these challenges and that there's growing research focusing on the genomic mutations specific to these types of breast cancer.
We also touch on the significance of patient-centric care, reminding listeners that they have the ultimate say in their treatment decisions. Amy shares her personal experience with her treatment regimen and the importance of sticking with what works unless there's a compelling reason to change.
The episode also covers the potential of contrasted mammograms and the need for different types of CT scans for accurate diagnosis. We stress the importance of being informed and advocating for oneself, as treatments can vary based on individual cancer properties.
As always, we remind our listeners that the information shared is from personal experiences and not a substitute for professional medical advice. We encourage reaching out to your medical care team with any questions or concerns.
00:02:46 - Dr. Mankoff's Research on Imaging Technology
00:04:02 - Genomic Mutations in Different Breast Cancer Types
00:04:34 - Clinical Trials and Research Timelines
00:04:56 - Genes Implicated in Inflammatory Breast Cancer
00:06:02 - Imaging Challenges with Lobular Breast Cancer
00:07:07 - Amino Acid Studies and PET-CT Imaging
00:09:19 - Personalized Treatment and Informed Questions